| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.38M | 17.71M | 19.96M | 12.11M | 9.93M | 10.96M |
| Gross Profit | 16.25M | 17.19M | 19.40M | 11.71M | 9.73M | 10.73M |
| EBITDA | 4.78M | 5.17M | 6.11M | 1.06M | 713.00K | 1.91M |
| Net Income | 3.63M | 4.05M | 6.02M | 1.31M | 723.00K | 1.53M |
Balance Sheet | ||||||
| Total Assets | 25.59M | 28.69M | 25.69M | 17.44M | 12.93M | 13.01M |
| Cash, Cash Equivalents and Short-Term Investments | 17.82M | 18.67M | 17.23M | 8.33M | 7.79M | 8.03M |
| Total Debt | 1.15M | 619.00K | 804.00K | 465.00K | 756.00K | 1.11M |
| Total Liabilities | 9.13M | 11.66M | 12.52M | 10.41M | 7.42M | 8.26M |
| Stockholders Equity | 16.46M | 17.03M | 13.18M | 7.03M | 5.51M | 4.75M |
Cash Flow | ||||||
| Free Cash Flow | 4.33M | 2.30M | 9.27M | 2.79M | 77.00K | 4.14M |
| Operating Cash Flow | 4.45M | 2.88M | 9.63M | 2.86M | 110.00K | 4.24M |
| Investing Cash Flow | -395.00K | -856.00K | -358.00K | -2.08M | -33.00K | -95.00K |
| Financing Cash Flow | -2.47M | -529.00K | -333.00K | -294.00K | -372.00K | -791.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £65.50M | 3.74 | ― | 4.16% | ― | ― | |
70 Outperform | £99.52M | 54.18 | 5.30% | ― | -3.95% | 16.87% | |
70 Outperform | £466.80M | 71.10 | 1.56% | 1.73% | -0.18% | 11.49% | |
64 Neutral | £61.37M | 20.75 | 23.08% | ― | -19.19% | -41.12% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £369.67M | 26.54 | ― | 2.16% | ― | ― | |
41 Neutral | £15.24M | -35.35 | -19.77% | ― | ― | ― |
Intercede Group has issued 200,000 new ordinary shares following the exercise of employee share options under its Enterprise Management Incentive Plan, with admission of the new shares to trading on AIM expected around 22 January 2026. The issuance increases the company’s total share capital to 60,536,452 ordinary shares, of which 60,162,546 carry voting rights after accounting for treasury shares, providing an updated denominator for investors monitoring disclosure thresholds under UK transparency rules and modestly expanding the company’s equity base through employee-related incentives.
The most recent analyst rating on (GB:IGP) stock is a Hold with a £126.00 price target. To see the full list of analyst forecasts on Intercede stock, see the GB:IGP Stock Forecast page.
Intercede Group has issued 150,000 new ordinary shares following the exercise of employee share options under its Enterprise Management Incentive Plan, with the new shares expected to be admitted to trading on AIM around 2 January 2026. After admission, the company will have 60,336,452 ordinary shares in issue, of which 373,906 are held in treasury, resulting in 59,962,546 voting rights, a figure shareholders can use to assess disclosure obligations under UK transparency rules.
The most recent analyst rating on (GB:IGP) stock is a Hold with a £142.00 price target. To see the full list of analyst forecasts on Intercede stock, see the GB:IGP Stock Forecast page.